Taysha Gene Therapies
TSHA
#6714
Rank
$0.48 B
Marketcap
$2.39
Share price
46.63%
Change (1 day)
79.70%
Change (1 year)

Revenue for Taysha Gene Therapies (TSHA)

Revenue in 2024 (TTM): $12.87 Million USD

According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM ) is $12.87 Million USD. In 2023 the company made a revenue of $15.45 Million USD an increase over the revenue in the year 2022 that were of $2.5 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taysha Gene Therapies from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $12.87 M-16.69%
2023 $15.45 M517.55%
2022 $2.5 M
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA